technologynetworks11 个月
Reveal More With the PacBio Revio System’s Exceptionally Accurate Long-Read Sequencing
The Revio system adds affordability, high throughput, and ease of use to a foundation of long reads, exceptional accuracy, and direct methylation detection. Accuracy—The Revio system provides reliable ...
Bar and Bench5 天
GameChanger Law acts on Peptris Tech out-licensing AI-discovered drug candidate to Revio
GameChanger Law Advisors advised Peptris Technologies on its licensing agreement with Revio Therapeutics for PEPR124 (RT001), ...
Analytics India Magazine9 天
Peptris Technologies Licenses India’s First AI-Discovered Drug Candidate to Revio ...
Under the deal, Peptris Technologies is licensing PEPR124 (RT001), a preclinical-stage drug, to Revio Therapeutics for ...
Pharmabiz9 天
Peptris Technologies out-licenses India’s first AI discovered drug candidate to Revio ...
Peptris Technologies, an AI-powered drug discovery company, announced that it has entered into a licensing agreement with Revio Therapeutics, a specialty pharma start-up focused on repurposing and ...
Nasdaq1 个月
PACB Stock Down Following In-Line Q4 Earnings, Revio Shipments Fall
The sequential growth in consumables was offset by lower Revio placements. Several countries in the region also faced government funding headwinds with respect to capital expenditures. The Europe ...